GGrantIndex
← Leaderboards

Jenell S Coleman

Johns Hopkins University

$4,734,272
Attributed
$7,312,660
Total exposure
3
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1M · FY201425
$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,312,660 · 3

By mechanism

R01$7,312,660 · 3

Top collaborators

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Top investigators on “Woman

Research focus

WomanHigh RiskHiv InfectionsAids PreventionHiv RiskUnited StatesPublic HealthOralEmtricitabineInflammatoryHeterosexualsImmuneTenofovirSexually ActiveCellsFemaleClinical TrialsReportingPredispositionSiteSexually Transmitted DiseasesObservational StudyProgestinsContraceptive Agents

Grant awards (14)

Improving HIV Prevention Services among Socioeconomically Disadvantaged Cis-gender Women$774,104
R01 · FY2025 · MH · contact PI
Improving HIV Prevention Services among Socioeconomically Disadvantaged Cis-gender Women$786,802
R01 · FY2024 · MH · contact PI
Improving HIV Prevention Services among Socioeconomically Disadvantaged Cis-gender Women$798,380
R01 · FY2023 · MH · contact PI
Improving HIV Prevention Services among Socioeconomically Disadvantaged Cis-gender Women$216,165
R01 · FY2023 · MH · contact PI
Improving HIV Prevention Services among Socioeconomically Disadvantaged Cis-gender Women$825,894
R01 · FY2022 · MH · contact PI
“Inflammation, Vaginal Microbiota, and STI/HIV Risk”$472,668
R01 · FY2020 · HD · contact PI
“Inflammation, Vaginal Microbiota, and STI/HIV Risk”$478,965
R01 · FY2019 · HD · contact PI
Inflammation, Vaginal Microbiota, and STI/HIV Risk$229,250
R01 · FY2019 · HD · contact PI
“Inflammation, Vaginal Microbiota, and STI/HIV Risk”$484,875
R01 · FY2018 · HD · contact PI
“Inflammation, Vaginal Microbiota, and STI/HIV Risk”$490,125
R01 · FY2017 · HD · contact PI
The effect of Depo-Provera on HIV susceptibility, immune activation, and PrEP PK$438,858
R01 · FY2017 · AI
The effect of Depo-Provera on HIV susceptibility, immune activation, and PrEP PK$438,858
R01 · FY2016 · AI
The effect of Depo-Provera on HIV susceptibility, immune activation, and PrEP PK$438,858
R01 · FY2015 · AI
The effect of Depo-Provera on HIV susceptibility, immune activation, and PrEP PK$438,858
R01 · FY2014 · AI